Jörg Hanrieder Selected Research

rimorphin

2/2012	MALDI imaging mass spectrometry of neuropeptides in Parkinson's disease.
1/2011	Imaging mass spectrometry reveals elevated nigral levels of dynorphin neuropeptides in L-DOPA-induced dyskinesia in rat model of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jörg Hanrieder Research Topics

Disease

15	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2016
14	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 09/2006
8	Amyloid Plaque 01/2022 - 01/2017
3	Gliosis 01/2018 - 12/2012
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 06/2014 - 09/2006
3	Parkinson Disease (Parkinson's Disease) 02/2012 - 01/2011
3	Dyskinesias (Dyskinesia) 02/2012 - 01/2011
2	Inflammation (Inflammations) 01/2018 - 07/2014
2	Pathologic Processes 01/2013 - 03/2009
2	Cataract (Cataracts) 01/2012 - 03/2009
2	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2009 - 03/2009
1	Neurobehavioral Manifestations 01/2021
1	Myocardial Infarction 01/2020
1	Dementia (Dementias) 01/2020
1	Disease Progression 01/2019
1	Neuroinflammatory Diseases 01/2018
1	Demyelinating Diseases (Demyelinating Disease) 01/2018
1	Type 2 Diabetes Mellitus (MODY) 07/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2015
1	Alexander Disease (Alexander's Disease) 03/2015
1	Asthma (Bronchial Asthma) 07/2014
1	Cocaine-Related Disorders (Cocaine Addiction) 09/2013
1	Exfoliation Syndrome 01/2012
1	Headache (Headaches) 01/2012
1	Substance-Related Disorders (Drug Abuse) 10/2011
1	Epilepsy (Aura) 10/2011
1	Hypoxia (Hypoxemia) 07/2007

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 11/2021 - 09/2006
10	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2016
8	Peptides (Polypeptides)IBA 11/2020 - 01/2011
7	LipidsIBA 01/2022 - 06/2014
7	Biomarkers (Surrogate Marker)IBA 01/2020 - 05/2008
5	Alanine (L-Alanine)FDA Link 07/2017 - 12/2012
4	Amyloid beta-PeptidesIBA 01/2021 - 01/2008
3	Levodopa (L Dopa)FDA LinkGeneric 02/2012 - 01/2011
3	NeuropeptidesIBA 02/2012 - 01/2011
3	Dynorphins (Dynorphin)IBA 02/2012 - 01/2011
2	Biological ProductsIBA 01/2019 - 01/2018
2	NeurotoxinsIBA 03/2015 - 07/2014
2	rimorphinIBA 02/2012 - 01/2011
2	alpha-neoendorphinIBA 02/2012 - 01/2011
2	Tyrosine (L-Tyrosine)FDA Link 02/2012 - 10/2011
2	Messenger RNA (mRNA)IBA 10/2011 - 01/2011
2	preproenkephalinIBA 10/2011 - 01/2011
1	IsotopesIBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	TroponinIBA 01/2020
1	Parathyroid Hormone-Related ProteinIBA 11/2019
1	LysophospholipidsIBA 01/2018
1	Dihydrotachysterol (AT 10)IBA 12/2017
1	GangliosidesIBA 07/2017
1	tau Proteins (tau Protein)IBA 01/2017
1	SphingolipidsIBA 01/2017
1	Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA 01/2016
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 07/2015
1	UbiquitinIBA 03/2015
1	PlectinIBA 03/2015
1	VimentinIBA 03/2015
1	SteroidsIBA 07/2014
1	OvalbuminIBA 07/2014
1	EndotoxinsIBA 07/2014
1	Methylphenidate (Ritalin)FDA LinkGeneric 09/2013
1	Cocaine (Cocaine HCl)IBA 09/2013
1	Pharmaceutical PreparationsIBA 09/2013
1	CalciumIBA 12/2012
1	Opioid Receptors (Opioid Receptor)IBA 02/2012
1	Substance PIBA 02/2012
1	Opioid Peptides (Opioid Peptide)IBA 10/2011
1	delta Opioid Receptors (delta Opioid Receptor)IBA 01/2011
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 01/2011
1	Leucine EnkephalinIBA 01/2011
1	Opioid Analgesics (Opioids)IBA 01/2011
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2011
1	Superoxide DismutaseIBA 01/2008
1	ApolipoproteinsIBA 01/2008
1	Transcription Factors (Transcription Factor)IBA 07/2007

Therapy/Procedure

5	Lasers (Laser) 01/2022 - 03/2009
1	Therapeutics 01/2020
1	Drug Therapy (Chemotherapy) 01/2011
1	Cyclotrons 09/2006